insights_auto
Parashikimi: 52.0% optimist·5.5% pesimist
Shko tek analizachevron_right
AMGN:NASDAQ
Amgen Inc
465,23Â US$
0,00%
(0,00) 1D
466,00Â US$
arrow_upward
+0,17% (+0,77)bedtimeJashtë orarit
Mbyllur: 10 nën, 4:00:01 m.d., GMT-5 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMGN...
Hap
465,70Â US$
I lartë
468,80Â US$
I ulët
459,45Â US$
Kapitalizimi i tregut
251,65Â mld
Vëllimi mesatar
2,81Â mln
Vëllimi
2,14Â mln
Dividendi
2,17%
Dividendi tremujor
2,52Â US$
Data e ndërprerjes së dividendit
21 gush 2026
Raporti çmim/fitim
26,98
Maksimumi 52-javor
483,99Â US$
Minimumi 52-javor
312,53Â US$
Fitimet për aksion
17,25Â US$
Beta
0,43
Aksionet në qarkullim
540,91Â mln
Numri i punonjësve
32 mijë
Hap
465,70Â US$
I lartë
468,80Â US$
I ulët
459,45Â US$
Kapitalizimi i tregut
251,65Â mld
Vëllimi mesatar
2,81Â mln
Vëllimi
2,14Â mln
Dividendi
2,17%
Dividendi tremujor
2,52Â US$
Data e ndërprerjes së dividendit
21 gush 2026
Raporti çmim/fitim
26,98
Maksimumi 52-javor
483,99Â US$
Minimumi 52-javor
312,53Â US$
Fitimet për aksion
17,25Â US$
Beta
0,43
Aksionet në qarkullim
540,91Â mln
Numri i punonjësve
32 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
CNBC
·
3 orë më parë
Explosive Options' Bob Lang on why he likes Amgen
Investing.com Canada
·
21 orë më parë
Form 4 Amgen Inc: Omar Ishrak (Director) For: 6 November By Investing.com
GuruFocus
·
1 ditë më parë
Amgen (AMGN) Highlights Cost-Effectiveness of Repatha in New Car
News Corp
·
1 ditë më parë
Amgen Inc. stock rises Monday, still underperforms market
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
SektoriHealth Care
Industria-
Uebsajtiamgen.com